| B cells and tertiary lymphoid structures promote immunotherapy response BA Helmink, SM Reddy, J Gao, S Zhang, R Basar, R Thakur, K Yizhak, ... Nature 577 (7791), 549-555, 2020 | 1668 | 2020 |
| Defining T cell states associated with response to checkpoint immunotherapy in melanoma M Sade-Feldman, K Yizhak, SL Bjorgaard, JP Ray, CG de Boer, ... Cell 175 (4), 998-1013. e20, 2018 | 1367 | 2018 |
| Resistance to checkpoint blockade therapy through inactivation of antigen presentation M Sade-Feldman, YJ Jiao, JH Chen, MS Rooney, M Barzily-Rokni, ... Nature communications 8 (1), 1136, 2017 | 804 | 2017 |
| Tumor necrosis factor-α blocks differentiation and enhances suppressive activity of immature myeloid cells during chronic inflammation M Sade-Feldman, J Kanterman, E Ish-Shalom, M Elnekave, E Horwitz, ... Immunity 38 (3), 541-554, 2013 | 335 | 2013 |
| Phenotype, specificity and avidity of antitumour CD8+ T cells in melanoma G Oliveira, K Stromhaug, S Klaeger, T Kula, DT Frederick, PM Le, ... Nature 596 (7870), 119-125, 2021 | 284 | 2021 |
| PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1+CD38hi cells and anti-PD-1 resistance V Verma, RK Shrimali, S Ahmad, W Dai, H Wang, S Lu, R Nandre, P Gaur, ... Nature immunology 20 (9), 1231-1243, 2019 | 256 | 2019 |
| New insights into chronic inflammation-induced immunosuppression J Kanterman, M Sade-Feldman, M Baniyash Seminars in cancer biology 22 (4), 307-318, 2012 | 225 | 2012 |
| Defining T cell states associated with response to checkpoint immunotherapy in melanoma M Sade-Feldman, K Yizhak, SL Bjorgaard, JP Ray, CG de Boer, ... Cell 176 (1), 404, 2019 | 201 | 2019 |
| Clinical Significance of Circulating CD33+CD11b+HLA-DR− Myeloid Cells in Patients with Stage IV Melanoma Treated with Ipilimumab M Sade-Feldman, J Kanterman, Y Klieger, E Ish-Shalom, M Olga, ... Clinical Cancer Research 22 (23), 5661-5672, 2016 | 195 | 2016 |
| Longitudinal proteomic analysis of severe COVID-19 reveals survival-associated signatures, tissue-specific cell death, and cell-cell interactions MR Filbin, A Mehta, AM Schneider, KR Kays, JR Guess, M Gentili, ... Cell Reports Medicine 2 (5), 2021 | 190 | 2021 |
| Predictors of responses to immune checkpoint blockade in advanced melanoma N Jacquelot, MP Roberti, DP Enot, S Rusakiewicz, N Ternès, S Jegou, ... Nature communications 8 (1), 592, 2017 | 189 | 2017 |
| Adverse immunoregulatory effects of 5FU and CPT11 chemotherapy on myeloid-derived suppressor cells and colorectal cancer outcomes J Kanterman, M Sade-Feldman, M Biton, E Ish-Shalom, A Lasry, ... Cancer research 74 (21), 6022-6035, 2014 | 164 | 2014 |
| Chronic inflammation and cancer: suppressing the suppressors M Baniyash, M Sade-Feldman, J Kanterman Cancer immunology, immunotherapy 63, 11-20, 2014 | 140 | 2014 |
| The lipogenic regulator SREBP2 induces transferrin in circulating melanoma cells and suppresses ferroptosis X Hong, W Roh, RJ Sullivan, KHK Wong, BS Wittner, H Guo, TD Dubash, ... Cancer discovery 11 (3), 678-695, 2021 | 128 | 2021 |
| Cyclophosphamide Promotes Chronic Inflammation–Dependent Immunosuppression and Prevents Antitumor Response in Melanoma A Sevko, M Sade-Feldman, J Kanterman, T Michels, CS Falk, L Umansky, ... Journal of Investigative Dermatology 133 (6), 1610-1619, 2013 | 121 | 2013 |
| Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs S Weingarten-Gabbay, S Klaeger, S Sarkizova, LR Pearlman, DY Chen, ... Cell 184 (15), 3962-3980. e17, 2021 | 109 | 2021 |
| SARS-CoV-2 viremia is associated with distinct proteomic pathways and predicts COVID-19 outcomes Y Li, AM Schneider, A Mehta, M Sade-Feldman, KR Kays, M Gentili, ... The Journal of Clinical Investigation 131 (13), 2021 | 108 | 2021 |
| Landscape of helper and regulatory antitumour CD4+ T cells in melanoma G Oliveira, K Stromhaug, N Cieri, JB Iorgulescu, S Klaeger, JO Wolff, ... Nature 605 (7910), 532-538, 2022 | 88 | 2022 |
| Plasma from patients with bacterial sepsis or severe COVID-19 induces suppressive myeloid cell production from hematopoietic progenitors in vitro M Reyes, MR Filbin, RP Bhattacharyya, A Sonny, A Mehta, K Billman, ... Science translational medicine 13 (598), eabe9599, 2021 | 65 | 2021 |
| CXCL9:SPP1 macrophage polarity identifies a network of cellular programs that control human cancers R Bill, P Wirapati, M Messemaker, W Roh, B Zitti, F Duval, M Kiss, JC Park, ... Science 381 (6657), 515-524, 2023 | 62 | 2023 |
